Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis (AD)”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Post-approval studies (Phase 4)Study completedNCT00119158
What this trial is testing

Combination Therapy for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Children's Hospital of Philadelphia 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102
Testing effectiveness (Phase 2)UnknownNCT05905133
What this trial is testing

Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
Connect Biopharm LLC 360
Large-scale testing (Phase 3)Not Yet RecruitingNCT07767253
What this trial is testing

Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 246
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678645
What this trial is testing

The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching

Who this might be right for
Primary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Atopic Dermatitis (AD)
RenJi Hospital 44
Not applicableUnknownNCT03458624
What this trial is testing

Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 14
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07377838
What this trial is testing

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 286
Not applicableLooking for participantsNCT05689151
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic DermatitisEczema
Pfizer 183
Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Not applicableNot Yet RecruitingNCT04730024
What this trial is testing

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 102
Large-scale testing (Phase 3)Study completedNCT05375929
What this trial is testing

Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India

Who this might be right for
Atopic Dermatitis
Pfizer 200
Not applicableActive Not RecruitingNCT05081557
What this trial is testing

Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 873
Not applicableUnknownNCT03962387
What this trial is testing

Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 98
Large-scale testing (Phase 3)Study completedNCT04417894
What this trial is testing

Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Who this might be right for
Moderate to Severe Atopic Hand and Foot Dermatitis
Regeneron Pharmaceuticals 133
Testing effectiveness (Phase 2)Looking for participantsNCT07297602
What this trial is testing

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

Who this might be right for
Atopic Dermatitis
Nora Mohamed Abdelrazik 36
Testing effectiveness (Phase 2)Study completedNCT04805411
What this trial is testing

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06727552
What this trial is testing

Barzolvolimab in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Celldex Therapeutics 131
Testing effectiveness (Phase 2)Looking for participantsNCT07298395
What this trial is testing

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Enveda Therapeutics 105
Large-scale testing (Phase 3)UnknownNCT05004324
What this trial is testing

Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Kang Stem Biotech Co., Ltd. 308
Next Page